Insight on the Molecular Envelope of Lipid-Bound Apolipoprotein E from Electron Paramagnetic Resonance Spectroscopy
Open accessAbstract
Although a high-resolution X-ray structure for the N-terminal domain of apolipoprotein E (apoE) in the lipid-free state has been solved, our knowledge of the structure of full-length apoE in a lipid-bound state is limited to an X-ray model fitting a molecular envelope at 10-A resolution. To add molecular detail to the molecular envelope, we used cysteine mutagenesis to incorporate spin labels for analysis with electron paramagnetic resonance (EPR) spectroscopy. Twelve cysteine residues were introduced singly and in pairs at unique locations throughout apoE4 and labeled with an EPR spin probe. The labeled apoE4 was combined with dipalmitoylphosphatidylcholine, the particles were purified, and spectra were determined for 24 combinations (single and double) of the cysteine mutants. Data on the conformation, mobility, distance, and surface exposure of regions revealed by the cysteine probes were modeled into the molecular envelope of apoE bound to dipalmitoylphosphatidylcholine that had been determined by X-ray analysis. This EPR model of apoE in a native lipid-bound state validates the structural model derived from X-ray analysis and provides additional insight into apoE structure-function relationships.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Structural differences among apoE isoforms, especially differences in relative affinities for various apoE receptors, may contribute to differences in Aβ clearance.
“The impact of structural differences among apoE isoforms (64), especially differences in relative affinities for various apoE receptors, may also contribute to differences in Aβ clearance.”
From Human ApoE isoforms differentially regulate brain amyloid-β peptide clearance (2011) · cites this paper as [64]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Apolipoprotein E: Structure-Function Relationships
Weisgraber, K. H. (1994) · Advances in Protein Chemistry · doi:10.1016/s0065-3233(08)60642-7 · Cited by 830 · see citing works
Self-citationThree-Dimensional Structure of the LDL Receptor-Binding Domain of Human Apolipoprotein E
Wilson, C., Wardell, M. R., Weisgraber, K. H., Mahley, R. W., & Agard, D. A. (1991) · Science · doi:10.1126/science.2063194 · Cited by 678 · see citing works
Self-citationApolipoprotein E structure: insights into function
Hatters, D. M., Peters-Libeu, C. A., & Weisgraber, K. H. (2006) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2006.06.008 · Cited by 583 · see citing works
Self-citationAggerbeck, L. P., Wetterau, J. R., Weisgraber, K. H., Wu, C. S., & Lindgren, F. T. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)68779-4 · Cited by 229 · see citing works
Self-citationAmino-terminal domain stability mediates apolipoprotein E aggregation into neurotoxic fibrils
Hatters, D. M., Zhong, N., Rutenber, E., & Weisgraber, K. H. (2006) · Journal of Molecular Biology · doi:10.1016/j.jmb.2006.06.080 · Cited by 105 · see citing works
Self-citation
Flagged first, then by citations
Research works printed but not linked: 38
- [2]Mahley RW Apolipoprotein E: cholesterol transport protein with expanding role in cell biology Science 1988 240 622 630 3283935
- [3]Nathan BP Bellosta S Sanan DA Weisgraber KH Mahley RW Pitas RE Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro Science 1994 264 850 852 8171342
- [5]Mahley RW Huang Y Apolipoprotein E: from atherosclerosis to Alzheimer's disease and beyond Curr. Opin. Lipidol 1999 10 207 217 10431657
- [6]Strittmatter WJ Saunders AM Schmechel D Pericak-Vance M Enghild J Salvesen GS Roses AD Apolipoprotein E: high-avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease Proc. Natl Acad. Sci. USA 1993 90 1977 1981 8446617 PMC46003
- [7]Corder EH Saunders AM Strittmatter WJ Schmechel DE Gaskell PC Small GW Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families Science 1993 261 921 923 8346443
- [8]Saunders AM Strittmatter WJ Schmechel D St George-Hyslop PH Pericak-Vance MA Joo SH Association of apolipoprotein E allele ε4 with late-onset familial and sporadic Alzheimer's disease Neurology 1993 43 1467 1472 8350998
- [9]Innerarity TL Pitas RE Mahley RW Binding of arginine-rich (E) apoprotein after recombination with phospholipid vesicles to the low density lipoprotein receptors of fibroblasts J. Biol. Chem 1979 254 4186 4190 220235
- [10]Peters-Libeu CA Newhouse Y Hatters DM Weisgraber KH Model of biologically active apolipoprotein E bound to dipalmitoylphosphatidylcholine J. Biol. Chem 2006 281 1073 1079 16278220
- [11]Hatters DM Budamagunta MS Voss JC Weisgraber KH Modulation of apolipoprotein E structure by domain interaction. Differences in lipid-bound and lipid-free forms J. Biol. Chem 2005 280 34288 34295 16076841
- [12]Narayanaswami V Szeto SSW Ryan RO Lipid association-induced N- and C-terminal domain reorganization in human apolipoprotein E3 J. Biol. Chem 2001 276 37853 37860 11483594
- [13]Gianturco SH Gotto AM Jr Hwang S-LC Karlin JB Lin AHY Prasad SC Bradley WA Apolipoprotein E mediates uptake of Sf 100-400 hypertriglyceridemic very low density lipoproteins by the low density lipoprotein receptor pathway in normal human fibroblasts J. Biol. Chem 1983 258 4526 4533 6300089
- [14]Weisgraber KH Mahley RW Kowal RC Herz J Goldstein JL Brown MS Apolipoprotein C-I modulates the interaction of apolipoprotein E with β-migrating very low density lipoproteins (β-VLDL) and inhibits binding of β-VLDL to low density lipoprotein receptor-related protein J. Biol. Chem 1990 265 22453 22459 2266137
- [15]Narayanaswami V Ryan RO Molecular basis of exchangeable apolipoprotein function Biochim. Biophys. Acta 2000 1483 15 36 10601693
- [16]Peters-Libeu CA Newhouse Y Hall SC Witkowska HE Weisgraber KH Apolipoprotein E-dipalmitoylphosphatidylcholine particles are ellipsoidal in solution J. Lipid Res 2007 48 1035 1044 17308333
- [19]Wetterau JR Aggerbeck LP Rall SC Jr Weisgraber KH Human apolipoprotein E3 in aqueous solution: I. Evidence for two structural domains J. Biol. Chem 1988 263 6240 6248 3360781
- [22]Matz CE Jonas A Micellar complexes of human apolipoprotein A-I with phosphatidylcholines and cholesterol prepared from cholate-lipid dispersions J. Biol. Chem 1982 257 4535 4540 6802835
- [23]Newhouse Y Peters-Libeu C Weisgraber KH Crystallization and preliminary x-ray diffraction analysis of apolipoprotein E-containing lipoprotein particles Acta Crystallogr., Sect. F 2005 61 981 984 PMC1978127 16511213
- [24]Langen R Oh KJ Cascio D Hubbell WL Crystal structures of spin labeled T4 lysozyme mutants: implications for the interpretation of EPR spectra in terms of structure Biochemistry 2000 39 8396 8405 10913245
- [25]Guo Z Cascio D Hideg K Kálái T Hubbell WL Structural determinant of nitroxide motion in spin-labeled proteins: tertiary contact and solvent-inaccessible sites in helix G of T4 lysozyme Protein Sci 2007 16 1069 1086 17473014 PMC2206656
- [26]Fajer MI Li H Yang W Fajer PG Mapping electron paramagnetic resonance spin label conformations by the simulated scaling method J. Am. Chem. Soc 2007 129 13840 13846 17948993
- [27]Mchaourab HS Oh KJ Fang CJ Hubbell WL Conformation of T4 lysozyme in solution. Hinge-bending motion and the substrate-induced conformational transition studied by site-directed spin labeling Biochemistry 1997 36 307 316 9003182
- [28]Segrest JP Jones MK Klon AE Sheldahl CJ Hellinger M Loof H-D Harvey SC A detailed molecular belt model for apolipoprotein A-I in discoidal high density lipoprotein J. Biol. Chem 1999 274 31755 31758 10542194
- [29]Qin Z Cafiso DS Membrane structure of protein kinase C and calmodulin binding domain of myristoylated alanine rich C kinase substrate determined by site-directed spin labeling Biochemistry 1996 35 2917 2925 8608129
- [30]Nielsen RD Che K Gelb MH Robinson BH A ruler for determining the position of proteins in membranes J. Am. Chem. Soc 2005 127 6430 6442 15853351
- [31]Oda MN Forte TM Ryan RO Voss JC The C-terminal domain of apolipoprotein A-I contains a lipid-sensitive conformational trigger Nat. Struct. Biol 2003 10 455 460 12754494
- [32]Martin DD Budamagunta MS Ryan RO Voss JC Oda MN Apolipoprotein A-I assumes a “looped belt” conformation on reconstituted high density lipoprotein J. Biol. Chem 2006 281 20418 20426 16698792
- [33]Lagerstedt JO Budamagunta MS Oda MN Voss JC Electron paramagnetic resonance spectroscopy of site-directed spin labels reveals the structural heterogeneity in the N-terminal domain of apoA-I in solution J. Biol. Chem 2007 282 9143 9149 17204472
- [34]Glomset JA The plasma lecithin:cholesterol acyltransferase reaction J. Lipid Res 1968 9 155 167 4868699
- [35]Gordon V Innerarity TL Mahley RW Formation of cholesterol- and apoprotein E-enriched high density lipoproteins in vitro J. Biol. Chem 1983 258 6202 6212 6343371
- [36]Koo C Innerarity TL Mahley RW Obligatory role of cholesterol and apolipoprotein E in the formation of large cholesterol-enriched and receptor-active high density lipoproteins J. Biol. Chem 1985 260 11934 11943 2995353
- [37]Dong L-M Wilson C Wardell MR Simmons T Mahley RW Weisgraber KH Agard DA Human apolipoprotein E. Role of arginine 61 in mediating the lipoprotein preferences of the E3 and E4 isoforms J. Biol. Chem 1994 269 22358 22365 8071364
- [38]Dong L-M Weisgraber KH Human apolipoprotein E4 domain interaction. Arginine 61 and glutamic acid 255 interact to direct the preference for very low density lipoproteins J. Biol. Chem 1996 271 19053 19057 8702576
- [39]Zhong N Scearce-Levie K Ramaswamy G Weisgraber KH Apolipoprotein E4 domain interaction: synaptic and cognitive deficits in mice Alzheimer's & Dementia 2008 4 179 192 PMC2647370 18631967
- [40]Ramaswamy G Xu Q Huang Y Weisgraber KH Effect of domain interaction on apolipoprotein E levels in mouse brain J. Neurosci 2005 25 10658 10663 16291938 PMC6725862
- [41]Raffaï RL Dong L-M Farese RV Jr Weisgraber KH Introduction of human apolipoprotein E4 “domain interaction” into mouse apolipoprotein E Proc. Natl Acad. Sci. USA 2001 98 11587 11591 11553788 PMC58773
- [42]Lu B Morrow JA Weisgraber KH Conformational reorganization of the four-helix bundle of human apolipoprotein E in binding to phospholipid J. Biol. Chem 2000 275 20775 20781 10801877
- [43]Fisher CA Narayanaswami V Ryan RO The lipid-associated conformation of the low density lipoprotein receptor binding domain of human apolipoprotein E J. Biol. Chem 2000 275 33601 33606 10906325
- [44]Morrow JA Arnold KS Weisgraber KH Functional characterization of apolipoprotein E isoforms overexpressed in Escherichia coli Protein Expression Purif 1999 16 224 230 10419818
Cited by
Sorted by citations
Human ApoE isoforms differentially regulate brain amyloid-β peptide clearance
Castellano, J. M., Kim, J., Stewart, F. R., Jiang, H., DeMattos, R. B., Patterson, B. W., Fagan, A. M., Morris, J. C., Mawuenyega, K. G., Cruchaga, C., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002156 · Cited by 1,227 · see citing works
“The impact of structural differences among apoE isoforms (64), especially differences in relative affinities for various apoE receptors, may also contribute to differences in Aβ clearance.”
Rasmussen, K. L. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.10.037 · Cited by 125 · see citing works
Current insights into apolipoprotein E and the immune response in Alzheimer's disease
Lin, P. B., & Holtzman, D. M. (2024) · Immunological Reviews · doi:10.1111/imr.13414 · Cited by 19 · see citing works
- Authors
- Hatters, D. M., Voss, J. C., Budamagunta, M. S., Newhouse, Y. N., & Weisgraber, K. H.
- Affiliations
- Gladstone Institutes (US)
- University of California, Davis (US)
- Corresponding author
- Weisgraber, Karl H.
- Venue
- Journal of Molecular Biology
- Publisher
- Elsevier BV
- Published
- 2009-02
- Volume
- 386
- Issue
- 1
- Pages
- 261-271
- ISSN
- 0022-2836 (ISSN-L)
- PMC
- PMC2665048
- OpenAlex
- W2051415561
- Cited by
- 28
- References
- 5
- Citations by year
- 2024: 5 · 2023: 3 · 2022: 1 · 2021: 2 · 2020: 2 · 2018: 1 · 2017: 1 · 2016: 2 · 2012: 2
- FWCI
- 1.63
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Molecular Biology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- National Institute on Aging (R01AG029246, R01AG028793, P01AG022074)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biophysics › Electron Spin Resonance Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Structure and Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Lipid Membrane Structure and Behavior
- Keywords
- apolipoprotein E, APOE ε4, molecular envelope, DPPC, spin labeling, cysteine mutants, protein-lipid interactions, protein conformation, protein mobility, surface exposure, structure-function relationship
- MeSH terms
- Apolipoproteins E, Binding Sites, Cysteine, Electron Spin Resonance Spectroscopy, Lipids, Models, Molecular, Protein Conformation, Recombinant Proteins, Spin Labels, 1,2-Dipalmitoylphosphatidylcholine, Mutagenesis, Site-Directed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review